These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 684037)

  • 1. Con A agglutination of DTIC-altered lymphoma cells.
    Nicolotti G; Gelfi P; Marelli O; Nicolin A
    Pharmacol Res Commun; 1978 Apr; 10(4):313-24. PubMed ID: 684037
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapeutic, carcinogenic, and cell-regulatory effects of triazenes.
    Schmid FA; Hutchison DJ
    Cancer Res; 1974 Jul; 34(7):1671-5. PubMed ID: 4833916
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of action and pharmacology studies with DTIC (NSC-45388).
    Loo TL; Housholder GE; Gerulath AH; Saunders PH; Farquhar D
    Cancer Treat Rep; 1976 Feb; 60(2):149-52. PubMed ID: 1260772
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the mechanism of action of DTIC (NSC-45388).
    Bono VH
    Cancer Treat Rep; 1976 Feb; 60(2):141-8. PubMed ID: 944096
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro lymphocyte stimulation and the generation of cytotoxic lymphocytes with drug-induced antigenic lymphomas.
    Testorelli C; Franco P; Goldin A; Nicolin A
    Cancer Res; 1978 Mar; 38(3):830-4. PubMed ID: 75062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunodepressive and hematotoxic activity of imidazole-4-carboxamide,5-(3,3-dimethyl-1-triazeno) in mice.
    Vecchi A; Fioretti MC; Mantovani A; Barzi A; Spreafico F
    Transplantation; 1976 Dec; 22(6):619-24. PubMed ID: 795112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of leukemic mice with viable drug-altered leukemic cells.
    Boerio D; Cavalli M; Marelli O; Veronese F; Nicolin A
    Ric Clin Lab; 1978; 8(3):127-33. PubMed ID: 746293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Depression of the immune response to lymphoma allotransplant with the use of 5-(3,3-dimethyl-1-triazeno)-imidazol-4-carboxamide (DTIC)].
    Giampietri A; Puccetti P; Circolo A; Menconi E
    Boll Soc Ital Biol Sper; 1977 Jun; 53(11):922-6. PubMed ID: 597414
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.
    Testorelli C; Archetti YL; Aresca P; Del Vecchio L
    Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concanavalin A-induced agglutination of human leukemic and lymphoma cells.
    Maca RD
    Cancer Res; 1976 Apr; 36(4):1218-21. PubMed ID: 1063062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3,3'-dimethyl-1-triazeno)imidazole-4-carboxamide.
    Contessa AR; Bonmassar A; Giampietri A; Circolo A; Goldin A; Fioretti MC
    Cancer Res; 1981 Jun; 41(6):2476-82. PubMed ID: 7016315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attempt to alter antigenic structure of normal tissues by treatment with dimethyl-triazeno-imidazole-carboxamide in vivo.
    Nicolin A; Fagnani R; Nicolotti G; Goldin A
    Experientia; 1976 Jun; 32(6):741-2. PubMed ID: 780128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased immunogenicity of two lymphoma lines after drug treatment of athymic (nude) mice.
    Campanile F; Houchens DP; Gaston M; Goldin A; Bonmassar E
    J Natl Cancer Inst; 1975 Jul; 55(1):207-9. PubMed ID: 1159815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of amine substances on susceptibility of cells to agglutination by concanavalin A and on paracrystal formation by vinblastine in untransformed 3T3 cells.
    Saito K; Kumagai K
    Tohoku J Exp Med; 1982 May; 137(1):91-9. PubMed ID: 6808705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosensitivity and histocompatibility antigens in drug-altered leukemic cells.
    Nicolin A; Franco P; Testorelli C; Goldin A
    Cancer Res; 1976 Jan; 36(1):222-7. PubMed ID: 1248001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and rejection patterns of murine lymphoma cells antigenically altered following drug treatment in vivo.
    Riccardi C; Fioretti MC; Giampietri A; Puccetti P; Goldin A
    Transplantation; 1978 Feb; 25(2):63-8. PubMed ID: 146282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylating activity in murine lymphoma cells xenogenized by triazene derivatives.
    Puccetti P; Fuschiotti P; Dominici P; Borri-Voltattorni C; Romani L; Fioretti MC
    Int J Cancer; 1987 Jun; 39(6):769-73. PubMed ID: 2438236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated response to a mouse leukemic subline antigenically altered following drug treatment in vivo.
    Nicolin A; Bini A; Franco P; Goldin A
    Cancer Chemother Rep; 1974; 58(3):325-30. PubMed ID: 4841716
    [No Abstract]   [Full Text] [Related]  

  • 19. [DTIC and its derivatives: cytotoxic or antimetastatic drugs?].
    Giraldi T; Sava G; Perissin L; Zorzet S; Tamaro M; Dolzani L
    G Ital Chemioter; 1985; 32(1):43-7. PubMed ID: 3830793
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibition of concanavalin A and phytohemagglutinine P mediated agglutination of L 1210 cells by different azomethines and possible relations to their cytostatic activity (author's transl)].
    Gutsche W; Schulze W; Augsten K; Jungstand W; Wohlrabe K; Wollweber L
    Arch Geschwulstforsch; 1979; 49(4):311-24. PubMed ID: 496569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.